TWD 17.6
(-3.3%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 27.12 Million TWD | -13.22% |
2022 | 31.25 Million TWD | -9.58% |
2021 | 34.56 Million TWD | -10.9% |
2020 | 38.79 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 FY | 27.12 Million TWD | -13.22% |
2023 Q2 | 29.63 Million TWD | -5.17% |
2023 Q4 | 27.12 Million TWD | -8.49% |
2022 Q4 | 31.25 Million TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 113.44 Million TWD | 76.094% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 90.437% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -3017.356% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 89.904% |
NaviFUS Corp. | 32.69 Million TWD | 17.043% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -399.374% |
TaiRx, Inc. | 12.28 Million TWD | -120.747% |
Sinew Pharma Inc. | 6.46 Million TWD | -319.57% |
Lin BioScience, Inc. | 42.87 Million TWD | 36.741% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -2216.055% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -115.075% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -1861.027% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 93.266% |
AP Biosciences Inc | 82.07 Million TWD | 66.957% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 84.421% |
RBC Bioscience Corporation | 487.36 Million TWD | 94.435% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 96.022% |
EirGenix Inc. | 465.16 Million TWD | 94.17% |
Enimmune corporation | 45.73 Million TWD | 40.698% |
Lukas Biomedical Inc. | 82.55 Million TWD | 67.148% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -655.039% |
3D Global Biotech Inc. | 10.37 Million TWD | -161.306% |
TaiMed Biologics Inc. | 750.85 Million TWD | 96.388% |
Mycenax Biotech Inc. | 726.27 Million TWD | 96.266% |
TCI GENE Inc. | 6.79 Million TWD | -299.132% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -1182.923% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 93.185% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -522.898% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -151.167% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | 72.009% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -240.246% |
Neith Corporation | 3.54 Million TWD | -665.914% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 93.071% |
VBI | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -359.834% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | 89.449% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -4941.078% |
CHO Pharma, Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -226.052% |
Visgeneer Inc. | 158.6 Million TWD | 82.9% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 86.172% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 53.405% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 93.496% |
Sagittarius Life Science Corp | 13.32 Million TWD | -103.565% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -107.157% |
GlycoNex Incorporation | 900 Thousand TWD | -2913.444% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.069% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | 81.214% |
PharmaEngine, Inc. | 14.8 Million TWD | -83.139% |
Intech Biopharm Corporation | 1.43 Billion TWD | 98.11% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 91.528% |
BiOptic Inc. | 93.19 Million TWD | 70.9% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 63.687% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -182.481% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -153.894% |
OBI Pharma, Inc. | 501.05 Million TWD | 94.587% |
Savior Lifetec Corporation | 270.37 Million TWD | 89.969% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -88.668% |
Level Biotechnology Inc. | 13.5 Million TWD | -100.867% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 98.626% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | 20.324% |
Acepodia, Inc. | 273.81 Million TWD | 90.095% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -32.569% |